Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muralimanohara S T Murala

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccines|May 28, 2025
Bovine Adenoviral Vector-Based Platform for Vaccine DevelopmentEkramy E Sayedahmed, Vivek Gairola, Muralimanohara S T Murala, et al.
Vaccines|May 7, 2025
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2Muralimanohara S T Murala, Vivek Gairola, Ekramy E Sayedahmed, et al.
Vaccines|January 24, 2025
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A VirusesWen-Chien Wang, Ekramy E Sayedahmed, Marwa Alhashimi, et al.
Molecular Therapy. Nucleic Acids|July 10, 2025
A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferretsWen-Chien Wang, Ekramy E Sayedahmed, Marwa Alhashimi, et al.
Journal of Nanobiotechnology|June 27, 2026
A Multiepitope Intranasal Adenoviral Vaccine Induces Robust Mucosal Immunity and Protection against SARS‑CoV‑2Ahmed Elkashif, Muralimanohara S T Murala, Carolyn M Lee, et al.
NPJ Vaccines|July 19, 2025
A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variantsMarwa Alhashimi, Ekramy E Sayedahmed, Ahmed Elkashif, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccines|May 28, 2025
Bovine Adenoviral Vector-Based Platform for Vaccine DevelopmentEkramy E Sayedahmed, Vivek Gairola, Muralimanohara S T Murala, et al.
Vaccines|May 7, 2025
Next-Generation Adenoviral Vector-Based Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2Muralimanohara S T Murala, Vivek Gairola, Ekramy E Sayedahmed, et al.
Vaccines|January 24, 2025
Adenoviral Vector-Based Vaccine Expressing Hemagglutinin Stem Region with Autophagy-Inducing Peptide Confers Cross-Protection Against Group 1 and 2 Influenza A VirusesWen-Chien Wang, Ekramy E Sayedahmed, Marwa Alhashimi, et al.
Molecular Therapy. Nucleic Acids|July 10, 2025
A bovine adenoviral-vector-based universal influenza vaccine confers protection against influenza A and B viruses in mice and ferretsWen-Chien Wang, Ekramy E Sayedahmed, Marwa Alhashimi, et al.
Journal of Nanobiotechnology|June 27, 2026
A Multiepitope Intranasal Adenoviral Vaccine Induces Robust Mucosal Immunity and Protection against SARS‑CoV‑2Ahmed Elkashif, Muralimanohara S T Murala, Carolyn M Lee, et al.
NPJ Vaccines|July 19, 2025
A multi-antigen-based SARS-CoV-2 vaccine provides higher immune responses and protection against SARS-CoV-2 variantsMarwa Alhashimi, Ekramy E Sayedahmed, Ahmed Elkashif, et al.
Pageof 1